Vicarious Surgical

RBOT · OTC

$0.0004−$0.0196 (−98.00%)TodayMarket closed · Oct 20, 4:41 PM ET

Prev close $0.02

Latest news

Press releaseMay 13, 9:00 AM ETGlobe Newswire
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
Press releaseApr 30, 8:30 AM ETGlobe Newswire
Vicarious Surgical Reports First Quarter 2026 Financial Results
Press releaseMar 30, 4:15 PM ETGlobe Newswire
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
Press releaseMar 25, 4:15 PM ETGlobe Newswire
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
Press releaseMar 4, 7:00 AM ETBusiness Wire
Vicarious Surgical Receives Delisting Notice From NYSE
Press releaseJan 12, 8:30 AM ETBusiness Wire
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
NewsJan 5, 4:27 AM ETAvi Kapoor
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Press releaseDec 29, 4:10 PM ETBusiness Wire
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations
Press releaseDec 15, 8:30 AM ETBusiness Wire
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
NewsDec 4, 4:48 AM ETAvi Kapoor
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Press releaseDec 3, 7:00 AM ETBusiness Wire
Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook
Press releaseNov 19, 4:15 PM ETBusiness Wire
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
Press releaseNov 12, 4:15 PM ETBusiness Wire
Vicarious Surgical Reports Third Quarter 2025 Financial Results
NewsNov 12, 6:11 AM ET
Earnings Scheduled For November 12, 2025
NewsNov 11, 2:03 PM ET
A Peek at Vicarious Surgical's Future Earnings
Press releaseNov 6, 6:13 PM ETBusiness Wire
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025
Press releaseOct 30, 4:05 PM ETBusiness Wire
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025
Press releaseOct 8, 7:00 AM ETBusiness Wire
Vicarious Surgical Announces Pricing of $5.9 Million Registered Direct Offering
Press releaseSep 25, 4:15 PM ETBusiness Wire
Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board
Press releaseAug 27, 4:15 PM ETBusiness Wire
Vicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Press releaseAug 12, 4:15 PM ETBusiness Wire
Vicarious Surgical Reports Second Quarter 2025 Financial Results
NewsAug 12, 4:32 AM ET
Earnings Scheduled For August 12, 2025
Press releaseJul 31, 4:30 PM ETBusiness Wire
Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer
Press releaseJul 29, 4:05 PM ETBusiness Wire
Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025
Press releaseJun 30, 6:45 AM ETBusiness Wire
Vicarious Surgical Announces Election of New Directors
Press releaseMay 28, 8:30 AM ETGlobe Newswire
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
Press releaseMay 12, 4:05 PM ETBusiness Wire
Vicarious Surgical Reports First Quarter 2025 Financial Results
Press releaseMay 12, 4:05 PM ETBusiness Wire
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center
NewsMay 12, 4:32 AM ET
Earnings Scheduled For May 12, 2025
NewsMay 9, 3:02 PM ET
Earnings Preview: Vicarious Surgical
Press releaseApr 28, 4:05 PM ETBusiness Wire
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025
Press releaseApr 11, 4:30 PM ETBusiness Wire
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE
Press releaseMar 24, 4:05 PM ETBusiness Wire
Vicarious Surgical Announces President Transition to Board Member Role
Press releaseMar 17, 4:05 PM ETBusiness Wire
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results
NewsMar 17, 4:32 AM ET
Earnings Scheduled For March 17, 2025
Press releaseMar 13, 8:30 AM ETBusiness Wire
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer
Press releaseMar 3, 4:05 PM ETBusiness Wire
Vicarious Surgical to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 17, 2025
NewsNov 12, 3:32 AM ET
Earnings Scheduled For November 12, 2024

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Receives Delisting Notice From NYSE

Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations

Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook

Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

Vicarious Surgical Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 12, 2025

A Peek at Vicarious Surgical's Future Earnings

Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025

Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025

Vicarious Surgical Announces Pricing of $5.9 Million Registered Direct Offering

Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board

Vicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Vicarious Surgical Reports Second Quarter 2025 Financial Results

Earnings Scheduled For August 12, 2025

Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

Vicarious Surgical Announces Election of New Directors

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Vicarious Surgical Reports First Quarter 2025 Financial Results

Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center

Earnings Scheduled For May 12, 2025

Earnings Preview: Vicarious Surgical

Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025

Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE

Vicarious Surgical Announces President Transition to Board Member Role

Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results

Earnings Scheduled For March 17, 2025

Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

Vicarious Surgical to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 17, 2025

Earnings Scheduled For November 12, 2024